DrugPatentWatch: Make Better Decisions around branded drug lifecycle management and generic entry with accurate, objective, and timely intelligence

Serving leading biopharmaceutical companies globally:

Harvard Business School

Moodys

Colorcon

Merck

Boehringer Ingelheim

AstraZeneca

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Solutions designed for all your needs

Reliable primary data + expert analysis. We provide answers for your burning questions

→ See why others have switched

Anticipate Generic Drug Launch

Stop Guessing!

Will a generic version of a drug launch? And when?

Expert analysis based on objective data.

Automated Reports

Stop Wasting Time & Money

How much time are you wasting on repetitive tasks?

DrugPatentWatch can take the load off of your team.

Say

Say 'NO' to Bad Contracts

Are you tired of having to navigate complicated contracts?

Let DrugPatentWatch free you…

What our Clients Say

❝ Quick and easy to understand summaries, along with all the necessary links for further analysis. ❞

Mid-Market Pharmaceutical Analyst

Automated Reports

Automated Reports & Custom Dashboards

Do more with less staff
Take the load off your team
Automate processes and focus on growing your business

Try Before You Buy

See Plans and Pricing

Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

Inform portfolio management decisions
Sector landscaping and due diligence
Track drugs in development and explore new indications for existing drugs

Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

Study failed patent challenges to develop a better strategy
Collect competitive intelligence by examining contractual disputes
Track litigation to anticipate early generic entry

Try Before You Buy

See Plans and Pricing

Drug Prices

Find and Evaluate Business Opportunities

Assess levels of generic competition
Use drug price ranges to evaluate price elasticity
Determine optimal prices before launch

Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

Assess market potential through historic sales figures
Evaluate buyer power with data on reimbursement segmentation
Align distribution methods with information on where and how drugs are purchased

Try Before You Buy

See Plans and Pricing

Global Drug Patents in 134 Countries

Global Drug Patents

Drug Patents in 134 Countries
Evaluate branded and generic market opportunities globally

Track 505(b)(2) entrants

Monitor 505(b)(2) and biosimilar activity

Anticipate 505(b)(2) and biosimilar approvals
Track OTC-switches, new formulations, biosimilars, and other drug improvements
Strengthen new formulation patents by studying prior claims and litigation

Try Before You Buy

See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck

Harvard Business School

McKesson

Colorcon

Medtronic

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.